European Respiratory Review

Article	Citations
The role of telemonitoring in patients on home mechanical ventilation	257
Reply to: “Nicotine or tobacco abstinence?”	188
European Respiratory Review, list of peer reviewers 2022	177
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis	124
Ventilation/perfusion mismatch is not the sole reason for hypoxaemia in early stage COVID-19 patients	122
Health disparities and associated social determinants of health in interstitial lung disease: a narrative review	120
Cough monitoring systems in adults with chronic respiratory diseases: a systematic review	112
European Respiratory Review, list of peer reviewers 2023	103
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension	100
Exacerbations of bronchiectasis	87
ERS/EAACI statement on adherence to international adult asthma guidelines	85
Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections	81
Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis	80
The re-emerging role of linoleic acid in paediatric asthma	77
Epidemiology of severe asthma in children: a systematic review and meta-analysis	76
Air pollution as an early determinant of COPD	76
Lung stem cells and respiratory epithelial chimerism in transplantation	70
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell	67
Multiple breath washout and oscillometry after allogenic HSCT: a scoping review	65
Quality of life in patients with chronic respiratory failure on home mechanical ventilation	64
Treatable traits in asthma during pregnancy: a call for a shift towards a precision-based management approach	59
Advance care planning in patients with respiratory failure	59
Global respiratory health priorities at the beginning of the 21st century	59
Inhaled corticosteroids for the treatment of COVID-19	58
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension	57

Diaphragm excursion and diaphragm thickening fraction: commonality and conflict	57
Characteristics of scores used for quantitative lung ultrasound in neonates: a systematic review	56
Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis	55
Sarcopenia in interstitial lung disease	54
Awake prone positioning for hypoxaemic respiratory failure: past, COVID-19 and perspectives	54
The ageing of people living with cystic fibrosis: what to expect now?	51
Contemporary issues in the implementation of lung cancer screening	51
Sex and gender in interstitial lung diseases	50
Integrating asthma care guidelines into primary care electronic medical records: a review focused on Canadian knowledge translation tools	49
Phenotype overlap in the natural history of asthma	48
Methods to assess COPD medications adherence in healthcare databases: a systematic review	47
Smoking cessation and vaccination	47
Nonpharmacological interventions in COPD	46
Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review	46
Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis	45
Measuring pulmonary function in COPD using quantitative chest computed tomography analysis	44
Pathophysiology and genomics of bronchiectasis	44
Sex and gender in respiratory physiology	43
Recreating chronic respiratory infectionsin vitrousing physiologically relevant models	42
Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis	41
Waterpipe smoking: a review of pulmonary and health effects	41
A pulmonologist's guide to perform and analyse cross-species single lung cell transcriptomics	41
REM sleep obstructive sleep apnoea	40
Airway ciliated cells in adult lung homeostasis and COPD	39
Investigating the prognostic value of digital mobility outcomes in patients with chronic obstructive pulmonary disease: a systematic literature review and meta-analysis	39
Mitogen-activated protein kinase-guided drug discovery for post-viral and related types of lung disease	38
Advanced imaging techniques and artificial intelligence in pleural diseases: a narrative review	38
Pro: Clinical remission in asthma – implications for asthma management	37
Sex and gender in pulmonary arterial hypertension	36
Extreme weather and asthma: a systematic review and meta-analysis	36
Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome	36
Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an indivi	36
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection	36
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future	36
Extrapulmonary effects of lung volume reduction in severe emphysema: a systematic review	34
Sex and gender in lung health and disease: more than just Xs and Ys	34
Interplay between respiratory viruses and cilia in the airways	34
Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis	34
The persistent inflammation in COPD: is autoimmunity the core mechanism?	33
The oesophageal balloon for respiratory monitoring in ventilated patients: updated clinical review and practical aspects	33
Subclinical tuberculosis: a meta-analysis of prevalence and scoping review of definitions, prevalence and clinical characteristics	33
COVID-19 and tuberculosis: the double whammy of respiratory pathogens	32
Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis	32
Bronchiolar disorders in systemic autoimmune rheumatic diseases	32
Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD	32
Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours	31
Preclinical models of maternal asthma and progeny outcomes: a scoping review	31
Adherence-enhancing interventions for pharmacological and oxygen therapy in patients with COPD: a systematic review and component network meta-analyses	31
Positive airway pressure therapy for post-stroke sleep disordered breathing: a systematic review, meta-analysis and meta-regression	31
Association between second-hand smoke exposure and lung cancer risk in never-smokers: a systematic review and meta-analysis	30

“Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms.” S. Malenfant, M. Lebret, É. Breton-Gagnon,et al.Eur Respir Rev	30
Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?	30
Does pulmonary rehabilitation address treatable traits? A systematic review	30
Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review	29
The epithelial era of asthma research: knowledge gaps and future direction for patient care	28
Parasitic lung diseases	28
Molecular monitoring of lung allograft health: is it ready for routine clinical use?	28
New trends in pulmonary hypertension	28
Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD	27
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD	27
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations	27
Evidence-based management of symptoms in serious respiratory illness: what is in our toolbox?	26
Fixed-intensity exercise tests to measure exertional dyspnoea in chronic heart and lung populations: a systematic review	26
Developments in radiation techniques for thoracic malignancies	26
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis	26
Predictors of sleep disordered breathing in children with Down syndrome: a systematic review and meta-analysis	25
From treatable traits to GETomics in airway disease: moving towards clinical practice	25
Impact of ageing and pregnancy on the minute ventilation/carbon dioxide production response to exercise	25
Breathing techniques to reduce symptoms in people with serious respiratory illness: a systematic review	25
A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?	24
Recycling plastic: diagnosis and management of plastic bronchitis among adults	24
E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials	24
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review	24
Stem cell therapy in pulmonary hypertension: current practice and future opportunities	23
Bronchiectasis in Asia: a review of current status and challenges	23
Supplemental oxygen for symptomatic relief in people with serious respiratory illness: a systematic review and meta-analysis	23
The association between alcohol consumption and pulmonary function: a scoping review	23
Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis	23
Impact of climate change on paediatric respiratory health: pollutants and aeroallergens	23
“Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD”. Ariel A. Calderon, Colin Dimond, David F. Choy, Rajita Pappu, Michele A. Grimb	22
Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis	22
Nitrogen single and multiple breath washout test and lung imaging to detect treatment-related pulmonary toxicity in paediatric cancer patients and survivors: a systematic review	22
Physical activity measurements in individuals with interstitial lung disease: a systematic review and meta-analysis	22
Digital twins for chronic lung diseases	22
Hypoxaemia in the early stage of COVID-19: prevalence of physical or biochemical factors?	22
Global birth prevalence of Robin sequence in live-born infants: a systematic review and meta-analysis	21
Biologics in severe asthma: the role of real-world evidence from registries	21
The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group	20
Antibody-mediated protection against respiratory syncytial virus in children	20
Cytokine-targeted therapies for asthma and COPD	20
The guardians of pulmonary harmony: alveolar macrophages orchestrating the symphony of lung inflammation and tissue homeostasis	20
Diaphragmatic palsy following lung transplantation	20
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis	20
Risk factors for asthma exacerbations during pregnancy: a systematic review and meta-analysis	20
Risk of serious COVID-19 outcomes among adults and children with moderate-to-severe asthma: a systematic review and meta-analysis	19
Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives	19
Lack of diversity in antifibrotic trials for pulmonary fibrosis: a systematic review	19
Inhaledversussystemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis	19
Protected characteristics reported in pulmonary rehabilitation: a scoping review	19
Nebulised granulocyte–macrophage colony-stimulating factor (GM-CSF) in autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis	18
In vivodetection of pulmonary mucociliary clearance: present challenges and future directions	18
Lung transplantation for COPD/pulmonary emphysema	18
Sex and gender in asthma	18
Gait differences between COPD and healthy controls: systematic review and meta-analysis	18
Clinimetric properties of field exercise tests in cystic fibrosis: a systematic review	17
Reporting of pre-existing multiple long-term conditions in physical rehabilitation for long COVID: a scoping review	17
How inhaled corticosteroids target inflammation in COPD	17
Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis	17
A narrative review of chemokine receptors CXCR1 and CXCR2 and their role in acute respiratory distress syndrome	17
“Strength of association between comorbidities and asthma: a meta-analysis” Paola Rogliani, Rossella Laitano, Josuel Ora, Richard Beasley and Luigino Calzetta.Eur Respir Rev2023; 32: 220202	17
Mediastinal tumours and pseudo-tumours: a comprehensive review with emphasis on multidisciplinary approach	17
Biomarkers in lower respiratory tract samples in the diagnosis of ventilator-associated pneumonia: a systematic review	17
Performance of alternative COPD case-finding tools: a systematic review and meta-analysis	17
The 6-min walk test as a primary end-point in interstitial lung disease	17
The effect of graded exercise therapy on fatigue in people with serious respiratory illness: a systematic review	17
Pulmonary rehabilitation and physical interventions	17
The flare of care for rare: per aspera ad astra for rare lung diseases!	16
Performance-based outcome measures to assess functionality in hospitalised patients with COPD exacerbations: a systematic review of the measurement properties	16
Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD	16
Forbearance with endobronchial stenting: cognisance before conviction	16
Guidance and standard operating procedures for functional exercise testing in cystic fibrosis	16
The evolution ofin vitromodels of lung fibrosis: promising prospects for drug discovery	16
CDK4/6 inhibitors in lung cancer: current practice and future directions	16
End-point definition and trial design to advance tuberculosis vaccine development	16
Update on recent key publications in lung oncology: picking up speed	16
Biochemical shunt: where and how?	16
Opioids for the palliation of symptoms in people with serious respiratory illness: a systematic review and meta-analysis	15
Perspectives for systems biology in the management of tuberculosis	15
Multicomponent services for symptoms in serious respiratory illness: a systematic review and meta-analysis	15
Predicting the pulmonary effects of long-term e-cigarette use: are the clouds clearing?	14

Understanding the pathogenesis of occupational coal and silica dust-associated lung disease	14
The role of vascularity and the fibrovascular interface in interstitial lung diseases	14
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis	14
Training in interventional pulmonology: the European and US perspective	14
“Noninvasive respiratory support after extubation: a systematic review and network meta-analysis”. A. Boscolo, T. Pettenuzzo, N. Sella, M. Zatta, M. Salvagno, M. Tassone, C. Pretto, A. Peralta, L. Mur	14
Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care	14
Airway epithelium in lung transplantation: a potential actor for post-transplant complications?	14
Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer	13
Clinical–radiological–pathological correlation in pulmonary hypertension with unclear and/or multifactorial mechanisms	13
Pulmonary veno-occlusive disease: illustrative cases and literature review	13
“How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?”. G. Hardavella, A. Frille, R. Chalela, K.B. Sreter, R.H. Petersen, N. Novoa and H.	13
No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis	13
“Immune mechanisms in fibrotic pulmonary sarcoidosis”. P. Weeratunga, D.R. Moller and L-P. Ho.Eur Respir Rev2022; 31: 220178	12
Phage therapy: breathing new tactics into lower respiratory tract infection treatments	12
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the “iMAging managEment of cySTic fibROsis” (MAESTRO) consortium	12
Managing respiratory muscle weakness during weaning from invasive ventilation	12
EMBARCing on a new era for bronchiectasis: a review series for the Seventh World Bronchiectasis Conference	12
Patient-reported outcomes to assess dyspnoea in interstitial lung disease and pulmonary hypertension: a systematic literature review of measurement properties	12
Sex, gender and the pulmonary physiology of exercise	12
Transient tachypnoea: new concepts on the commonest neonatal respiratory disorder	12
Platelets: a potential role in chronic respiratory diseases?	12
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline	12
Physical activity promotion interventions in chronic airways disease: a systematic review and meta-analysis	12
Particulate matter-induced epigenetic modifications and lung complications	11
Neutrophil serine proteases in cystic fibrosis: role in disease pathogenesis and rationale as a therapeutic target	11
Nine controversial questions about augmentation therapy for alpha-1 antitrypsin deficiency: a viewpoint	11
Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease	11
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review	11
A systematic review of procedural and sampling techniques for cryobiopsy in interstitial lung disease	11
Airborne indoor allergen serine proteases and their contribution to sensitisation and activation of innate immunity in allergic airway disease	11
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews	11
Fine particulate matter manipulates immune response to exacerbate microbial pathogenesis in the respiratory tract	11
Treating central sleep apnoea in heart failure: is positive airway pressure and adaptive servo-ventilation in particular the gold standard?	11
Respiratory management of acute chest syndrome in children with sickle cell disease	11
Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis	11
Nocturnal oxygen therapy in obstructive sleep apnoea: a systematic review and meta-analysis	10
Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians	10
“Design of pulmonary rehabilitation programmes during acute exacerbations of COPD: a systematic review and network meta-analysis.” Ana Machado, Pedro Matos Silva, Vera Afreixo, Cátia Caneiras, Chris B	10
Strength of association between comorbidities and asthma: a meta-analysis	10
Unsupervised home spirometryversussupervised clinic spirometry for respiratory disease: a systematic methodology review and meta-analysis	10
Thank you from the Chief Editor (2022–2024)	10
Exploring the translational landscape of the long noncoding RNA transcriptome in acute respiratory distress syndrome: it is a long way to the top	10
Severe COVID-19versusmultisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection	10
Pulmonary capillary recruitment and distention in mammalian lungs: species similarities	10
A role for club cells in smoking-associated lung adenocarcinoma	10
Extracorporeal carbon dioxide removal in acute hypoxaemic respiratory failure: a systematic review, Bayesian meta-analysis and trial sequential analysis	9
Neutrophilic inflammation in bronchiectasis	9
Assessing adherence to inhaled therapies in asthma and the emergence of electronic monitoring devices	9
Rare genetic interstitial lung diseases: a pictorial essay	9
Ventilatory efficiency in athletes, asthma and obesity	9
Efficacy and safety of gefapixant for chronic cough: a meta-analysis of randomised controlled trials	9
Ear and upper airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review	9
Medication adherence, related factors and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: a systematic review	9
Air pollution, metabolites and respiratory health across the life-course	9
Respiratory muscle dysfunction in acute and chronic respiratory failure: how to diagnose and how to treat?	9
Pulmonary aspergillosis: diagnosis and treatment	9
European Respiratory Review, list of peer reviewers 2024	9
The measurement properties of tests and tools used in cystic fibrosis studies: a systematic review	8
The world of rare interstitial lung diseases	8
Con: clinical remission in asthma – not yet there	8
The effects of COVID-19 on respiratory muscle performance: making the case for respiratory muscle testing and training	8
“Sex and gender differences during the lung lifespan: unveiling a pivotal impact” P. Tondo, C. Meschi, M. Mantero, G. Scioscia, M. Siciliano, M. Bradicich and G.M. Stella, on behalf of the Italian Res	8
Interstitial pneumonia with autoimmune features: challenges and controversies	8
Non-typeableHaemophilus influenzaeairways infection: the next treatable trait in asthma?	8
The deadly dance of alveolar macrophages and influenza virus	8
Home mechanical ventilation in children: evolving indications in an era of new treatment options	8
Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure	8
Interventions for the management of malignant pleural effusions: an updated network meta-analysis	8
Peripheral blood monocyte count and outcomes in patients with interstitial lung disease: a systematic review and meta-analysis	8
Noncoding RNAs in asthmatic airway smooth muscle cells	8
Multidisciplinary management of tracheobronchial injury	8
Animal models of silicosis: fishing for new therapeutic targets and treatments	8